MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis

Journal of Hepatology

Volumn 42, Issue 5, 2005, Pages 700-706

  Srikureja, Wichit ^a   Kyulo, Namgyal L ^a,c   Runyon, Bruce A ^a,b   Hu, Ke Qin ^a,c  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcoholic hepatitis; MELD score; Mortality; Retrospective study; Sensitivity; Specificity

Indexed keywords

ADULT; AGED; ALCOHOL LIVER DISEASE; AREA UNDER THE CURVE; CONTROLLED STUDY; FEMALE; HEALTH CENTER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 17044398456     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.12.022     Document Type: Article

References (15)

1. V.T. Savolainen, K. Liesto, A. Mannikko, A. Penttila, and P.J. Karhunen Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol Alcohol Clin Exp Res 17 1993 1112 1117
2. W.C. Maddrey Alcohol-induced liver disease Clin Liver Dis 4 2000 115 131
3. H.P. Porter, F.R. Simon, C.E. Pope, W. Volwiler, and F. Fenster Corticosteroid therapy in severe alcoholic hepatitis, a double-blind trial N Engl J Med 284 1971 1350 1355
4. W.C. Maddrey, J.K. Boitnott, M.S. Bedine, F.L. Weber Jr, E. Mezey, and R.I. White Jr Corticosteroid therapy of alcoholic hepatitis Gastroenterology 75 1978 193 199
5. T.F. Imperiale, and A.J. McCullough Do corticosteroids reduce mortality from alcoholic hepatitis? Ann Intern Med 113 1990 299 307
6. P. Mathurin, C.L. Mendenhall, R.L. Carithers, M.J. Ramond, W.C. Maddrey, and P. Garstide Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH J Hepatol 36 2002 480 487
7. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial Gastroenterology 119 2000 1637 1648
8. A. Chedid, C.L. Mendenhall, P. Gartside, S.W. French, T. Chen, and L. Rabin Prognostic factors in alcoholic liver disease Am J Gastroenterol 86 1991 210 216
9. R. Kumashiro, M. Sata, K. Ishii, Y. Koga, S. Fururdera, and J. Seo Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression Alcohol Clin Exp Res 20 1996 383A 386A
10. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
11. M. Sheth, M. Riggs, and T. Patel Utility of the Mayo end-stage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis BMC Gastroenterol 2 2002 2
12. R. Sarper, and Y.A. Tarcan An improved method of estimating the portal venous function of total hepatic blood flow from computerized radionuclide angiography Radiology 147 1983 559 562
13. V. Arroyo, P. Gines, and A.L. Gerbes Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club Hepatology 23 1996 164 176
14. K.V.N. Menon, G.J. Gores, and V.H. Shah Pathogenesis, diagnosis, and treatment of alcoholic liver disease Mayo Clin Proc 76 2001 1021 1029
15. M.Y. Morgan The treatment of alcoholic hepatitis Alcohol Alcohol 31 1996 117 134